Suchergebnisse - "van der Heijde, Désirée"

PubPharm (11)

1

Post hoc analysis of clinical characteristics of patients with radiographic progression in a Japanese phase 3 trial of peficitinib and methotrexate treatment (RAJ4)

enthalten in: Modern rheumatology | 2023

von Tanaka, Y. | Takeuchi, T. | Kato, D. | +5

2

Efficacy and safety of certolizumab pegol plus methotrexate in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate : the J-RAPID randomized, placebo-controlled trial

enthalten in: Modern rheumatology | 2014

von Yamamoto, K. | Takeuchi, T. | Yamanaka, H. | +10

3

Efficacy and safety of certolizumab pegol without methotrexate co-administration in Japanese patients with active rheumatoid arthritis : the HIKARI randomized, placebo-controlled trial

enthalten in: Modern rheumatology | 2014

von Yamamoto, K. | Takeuchi, T. | Yamanaka, H. | +10

4

Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI : data from the SAMURAI study

enthalten in: Modern rheumatology | 2011

von Hashimoto, J. | Garnero, P. | van der Heijde, D. | +6

5

Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study

enthalten in: Modern rheumatology | 2010

von Hashimoto, J. | Garnero, P. | van der Heijde, D. | +6

6

Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study

enthalten in: Modern rheumatology | 2010

von Hashimoto, J. | Garnero, P. | van der Heijde, D. | +6

7

Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study

enthalten in: Modern rheumatology | 2010

von Hashimoto, J. | Garnero, P. | van der Heijde, D. | +6

8

A combination of biochemical markers of cartilage and bone turnover, radiographic damage and body mass index to predict the progression of joint destruction in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs

enthalten in: Modern rheumatology | 2009

von Hashimoto, J. | Garnero, P. | van der Heijde, D. | +6

9

A combination of biochemical markers of cartilage and bone turnover, radiographic damage and body mass index to predict the progression of joint destruction in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs

enthalten in: Modern rheumatology | 2009

von Hashimoto, J. | Garnero, P. | van der Heijde, D. | +6

10

A combination of biochemical markers of cartilage and bone turnover, radiographic damage and body mass index to predict the progression of joint destruction in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs

enthalten in: Modern rheumatology | 2009

von Hashimoto, J. | Garnero, P. | van der Heijde, D. | +6